Cargando…
Prognostic index of aberrant mRNA splicing profiling acts as a predictive indicator for hepatocellular carcinoma based on TCGA SpliceSeq data
Alternative splicing in tumor cells may be used as a molecular marker for the differential diagnosis of certain tumor types and assessment of prognosis. The aim of the present study was to investigate the associations among alternative splicing events, splicing factors, and the survival of patients...
Autores principales: | Wu, Hua-Yu, Peng, Zhi-Gang, He, Rong-Quan, Luo, Bin, Ma, Jie, Hu, Xiao-Hua, Dang, Yi-Wu, Chen, Gang, Pan, Shang-Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615926/ https://www.ncbi.nlm.nih.gov/pubmed/31268164 http://dx.doi.org/10.3892/ijo.2019.4834 |
Ejemplares similares
-
Identification of survival-associated alternative splicing events and signatures in adrenocortical carcinoma based on TCGA SpliceSeq data
por: Xu, Ning, et al.
Publicado: (2020) -
Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases
por: Cheng, Xiaohu, et al.
Publicado: (2020) -
SpliceSeq: a resource for analysis and visualization of RNA-Seq data on alternative splicing and its functional impacts
por: Ryan, Michael C., et al.
Publicado: (2012) -
Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data
por: Ye, Ping, et al.
Publicado: (2021) -
Systematic analysis and prediction model construction of alternative splicing events in hepatocellular carcinoma: a study on the basis of large-scale spliceseq data from The Cancer Genome Atlas
por: Yang, Lingpeng, et al.
Publicado: (2019)